Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell ParkRoswell Park Comprehensive Cancer Center
Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of Alex A. Adjei, MD, PhD, the Katherine Anne Gioia Chair in Cancer Medicine, will accelerate the development of new and promising cancer therapies and expand treatment options for patients at Roswell Park and elsewhere. Dr. Adjei is a distinguished national leader in translational research, drug development, thoracic oncology and phase I clinical research programs.